Celldex Therapeutics, Inc. (CLDX)
34.03
-0.35
(-1.02%)
USD |
NASDAQ |
Apr 21, 10:16
Celldex Therapeutics Market Cap : 2.265B for April 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 49.61M |
| Atossa Therapeutics, Inc. | 50.55M |
| Abeona Therapeutics, Inc. | 316.62M |
| Cell Source, Inc. | 37.83M |
| Kiora Pharmaceuticals, Inc. | 10.11M |
Market Cap Related Metrics
| PS Ratio | 1462.04 |
| PEG Ratio | -0.1473 |
| Price to Book Value | 4.297 |
| Price | 34.03 |
| Earnings Yield | -11.45% |
| PEGY Ratio | -0.1473 |